Helen E. Bryant
Impact in
- Oncology top 0.2%
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
- Cancer Research top 1%
Papers in
-
- DNA Repair Mechanisms 27
- CRISPR and Genetic Engineering 8
- Cancer therapeutics and mechanisms 5
- Oncology 30
- PARP inhibition in cancer therapy 19
- Co-authors
- Thomas Helleday (15 shared papers)Niklas Schultz (6 shared papers)Mark Meuth (3 shared papers)Nicola J. Curtin (3 shared papers)Suzanne Kyle (2 shared papers)Elena López‐Knowles (2 shared papers)Huw D. Thomas (2 shared papers)Luke K. McKenzie (9 shared papers)
- Journals
- Oncotarget (5 papers)DNA repair (4 papers)Nucleic Acids Research (3 papers)Journal of Virology (3 papers)Journal of Biological Chemistry (3 papers)
- Partner nations
- United KingdomUnited StatesSweden
In The Last Decade
Helen E. Bryant
68 papers receiving 8.0k citations
Helen E. Bryant's Hit Papers
Peers
Comparison fields: 5 of 124
- Oncology 4.6k
- Cancer Research 1.1k
- Molecular Biology 5.0k
- Reproductive Medicine 256
- Immunology 570
Countries citing papers authored by Helen E. Bryant
This map shows the geographic impact of Helen E. Bryant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen E. Bryant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen E. Bryant more than expected).
Fields of papers citing papers by Helen E. Bryant
This network shows the impact of papers produced by Helen E. Bryant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen E. Bryant. The network helps show where Helen E. Bryant may publish in the future.
Co-authors
The 25 scholars most cited alongside Helen E. Bryant, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase Hit paper breakdown → | 2005 | 3823 |
| 2 | 2009 | 483 | |
| 3 | Transition metal complexes as photosensitisers in one- and two-photon photodynamic therapy Hit paper breakdown → | 2018 | 363 |
| 4 | 2005 | 272 | |
| 5 | 2009 | 271 | |
| 6 | 2015 | 202 | |
| 7 | 2014 | 189 | |
| 8 | 2010 | 168 | |
| 9 | 2016 | 165 | |
| 10 | 2006 | 156 | |
| 11 | 2016 | 155 | |
| 12 | 2005 | 139 | |
| 13 | 2010 | 130 | |
| 14 | 2016 | 93 | |
| 15 | 2020 | 87 | |
| 16 | 2009 | 78 | |
| 17 | 2012 | 77 | |
| 18 | 1999 | 75 | |
| 19 | 2020 | 75 | |
| 20 | 2017 | 67 |
About Helen E. Bryant
Helen E. Bryant is a scholar working on Molecular Biology, Oncology, Materials Chemistry, Pulmonary and Respiratory Medicine and Cancer Research, having authored 69 papers that have together received 8.1k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (27 papers), PARP inhibition in cancer therapy (19 papers), CRISPR and Genetic Engineering (8 papers), Photodynamic Therapy Research Studies (7 papers), Neuroblastoma Research and Treatments (5 papers), Lanthanide and Transition Metal Complexes (5 papers), Cancer therapeutics and mechanisms (5 papers) and Nanoplatforms for cancer theranostics (5 papers). The work is most often cited by research in Oncology (4.6k citations), Cancer Research (1.1k citations), Molecular Biology (5.0k citations), Reproductive Medicine (256 citations) and Immunology (570 citations). Helen E. Bryant has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include Thomas Helleday, Niklas Schultz, Mark Meuth, Nicola J. Curtin, Suzanne Kyle, Elena López‐Knowles, Huw D. Thomas, Luke K. McKenzie, Julia A. Weinstein and Daniel Yeomanson. Their work appears in journals such as Oncotarget, DNA repair, Nucleic Acids Research, Journal of Virology and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.